Outcomes Differences of Seronegative and Seropositive Pediatric Autoimmune Encephalitis
Annals of the Child Neurology Society · 15.11.2026
DOI: 10.1002/cns3.70097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Child Neurology Society, online erschienen am 15.11.2026. Verfasst von Jesus Angel Dominguez‐Rojas und 15 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Autoimmune encephalitis (AE) in children represents a group of immune‐mediated brain disorders with mild to severe neurological complications that are mostly recoverable with appropriate timely therapy. AE is complicated to diagnose and manage, particularly in Latin America, where access to diagnostic tests and treatments is limited. This study aimed to compare clinical outcomes in pediatric patients with AE who tested positive for autoantibodies versus those who tested negative.
Methods
We conducted a retrospective cohort, secondary analysis of the multicenter study REAL LABIC, including data from multiple countries in Latin America. We divided patients with AE into two groups based on their autoimmune antibody status: those with positive antibodies (Ab+) and those with negative antibodies (Ab−). We compared presentation, treatment responses, and clinical outcomes between the two groups.
Results
A total of 37 (59.7%) were Ab+, while 25 (40.3%) were Ab−. Neurological symptoms at admission were similar between groups, except for behavioral disturbances, which were more frequent in Ab+ patients (89% vs. 60%, p = 0.012) and required more aggressive treatment, including second‐line therapies, intensive care unit (ICU) admission, and mechanical ventilation.
Conclusions
Children with antibody‐positive AE in Latin America had a more severe disease course and required more intensive therapeutic interventions than antibody‐negative patients. These findings underscore the importance of timely diagnosis and equitable access to advanced diagnostic and therapeutic resources in the region.
Zitieren
APA
Dominguez‐Rojas, J. A., Vasquez‐Hoyos, P., Vences, M. A., Alarcon‐Ruiz, C. A., Johnston, C., Suarez‐Loro, M. A., Garcia‐Arellano, M., Lima, C. L. Q. D., Barrientos‐Guerra, J. D., Vela‐Sosa, R., Julian, C. R., Perales‐Caballero, K., Roa‐Giraldo, J. D., Godoy, D. A., Pena, V. A., & Coronado‐Munoz, A. (2026). Outcomes Differences of Seronegative and Seropositive Pediatric Autoimmune Encephalitis. Annals of the Child Neurology Society. https://doi.org/10.1002/cns3.70097
Vancouver
Dominguez‐Rojas JA, Vasquez‐Hoyos P, Vences MA, Alarcon‐Ruiz CA, Johnston C, Suarez‐Loro MA, et al. Outcomes Differences of Seronegative and Seropositive Pediatric Autoimmune Encephalitis. Annals of the Child Neurology Society. 2026. doi:10.1002/cns3.70097
BibTeX
@article{DominguezRojas2026,
author = {Dominguez‐Rojas, Jesus Angel and Vasquez‐Hoyos, Pablo and Vences, Miguel A. and Alarcon‐Ruiz, Christoper A. and Johnston, Cintia and Suarez‐Loro, Mercedes A. and Garcia‐Arellano, Maricela and Lima, Cibele Lopes Queiroz de and Barrientos‐Guerra, Jose Domingo and Vela‐Sosa, Ruth and Julian, Carmen Rojas and Perales‐Caballero, Karen and Roa‐Giraldo, Juan David and Godoy, Daniel A. and Pena, Veronica Alana and Coronado‐Munoz, Alvaro},
title = {Outcomes Differences of Seronegative and Seropositive Pediatric Autoimmune Encephalitis},
journal = {Annals of the Child Neurology Society},
year = {2026},
doi = {10.1002/cns3.70097}
}
EUVIMED